INmune Bio, Inc(NASDAQ:INMB) 
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer Alzheimer's disease, and non-alcoholic steatohepatitis. The company intends to develop and commercialize product candidates to treat hematologic malignancies, solid t...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 7.77
H 7.89
L 7.02
C 7.27
V 504,196
10EMA 7.27
20EMA 7.27
60EMA 7.27
120EMA 7.27
250EMA 7.27